Literature DB >> 10809854

Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions.

D Lipsker1, D Spehner, R Drillien, P Schmitt, B Cribier, E Heid, R L Humbel, E Grosshans.   

Abstract

The Schnitzler syndrome is the association of chronic urticaria, intermittent fever, osteosclerotic bone lesions and a monoclonal IgM gammopathy. It is not yet firmly established whether the monoclonal immunoglobulin component plays a part in the pathophysiology of the urticarial lesions. Immunoblotting on epidermal and dermal human skin extracts as well as immunoelectron microscopic (IEM) studies on Lowicryl K4M-embedded skin sections were performed in three patients with the Schnitzler syndrome. Western blotting on epidermal extracts showed the presence of IgM-kappa antiskin autoantibodies in two patients. These antibodies displayed the same isotype as the monoclonal components and recognized a 280-290-kDa antigen in one patient and a 200-kDa antigen in the other patient. IEM studies showed sparse IgM deposits in the epidermis, around the keratinocytes, near the desmosomes in one patient and dense deposits below the lamina densa, in the region of the anchoring fibrils, in another patient. Antiskin IgM autoantibodies of the same isotype as their monoclonal gammopathies can be present in the serum of some patients with the Schnitzler syndrome. These IgM antibodies seem to deposit in vivo in the epidermis and at the dermal-epidermal junction, in the region of the anchoring fibrils. These findings suggest that the monoclonal gammopathy plays a part in the pathophysiology of the skin rash. They also suggest patient heterogeneity both in the skin antigens that are recognized as well as in their localization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809854     DOI: 10.1046/j.1365-2133.2000.03477.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

1.  [Interleukin-1 cytokines, inflammasomes, NOD-signalosomes and autoinflammation].

Authors:  S D Gadola
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

2.  Schnitzler syndrome with cold-induced urticaria.

Authors:  Anil Kurian; Jason K Lee; Peter Vadas
Journal:  J Dermatol Case Rep       Date:  2010-12-31

3.  Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation.

Authors:  Cecilia A Larocca; John W McEvoy; Carla L Ellis; Jacqueline Junkins-Hopkins; Todd Kolb; Alan N Baer; Brian T Garibaldi
Journal:  Clin Rheumatol       Date:  2011-06-28       Impact factor: 2.980

4.  Beneficial response to anakinra and thalidomide in Schnitzler's syndrome.

Authors:  H D de Koning; E J Bodar; A Simon; J C H van der Hilst; M G Netea; J W M van der Meer
Journal:  Ann Rheum Dis       Date:  2005-08-11       Impact factor: 19.103

5.  [Adult-onset Still's disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood].

Authors:  P Lamprecht
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 6.  The Schnitzler syndrome.

Authors:  Dan Lipsker
Journal:  Orphanet J Rare Dis       Date:  2010-12-08       Impact factor: 4.123

Review 7.  Schnitzler's syndrome: lessons from 281 cases.

Authors:  Heleen D de Koning
Journal:  Clin Transl Allergy       Date:  2014-12-05       Impact factor: 5.871

8.  A Rare but Fascinating Disorder: Case Collection of Patients with Schnitzler Syndrome.

Authors:  Maaman Bashir; Brittany Bettendorf; Richard Hariman
Journal:  Case Rep Rheumatol       Date:  2018-03-08

9.  Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome.

Authors:  Shelly Pathak; Dorota Rowczenio; Samuel Lara-Reyna; Mark Kacar; Roger Owen; Gina Doody; Karoline Krause; Helen Lachmann; Rainer Doffinger; Darren Newton; Sinisa Savic
Journal:  Front Immunol       Date:  2020-12-03       Impact factor: 7.561

10.  Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patients.

Authors:  Christelle Darrieutort-Laffite; Catherine Ansquer; Hélène Aubert; Françoise Kraeber-Bodéré; Agathe Masseau; Christian Agard; Mohamed Hamidou; Claire Bernier; Jean-Marie Berthelot; Benoit Le Goff; Sébastien Barbarot; Antoine Néel
Journal:  Arthritis Res Ther       Date:  2020-11-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.